Drug intelligence / Profile preview

MWN117

Development stage
Phase 1
Lead developer
Shanghai Minwei Biotechnology
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Subcutaneous
01

Overview

MWN117 is an investigational small interfering RNA (siRNA) therapeutic designed to target inhibin subunit beta E (INHBE) for the treatment of overweight and obesity. Developed by Shanghai Minwei Biotechnology, a subsidiary of Lepu Medical, MWN117 downregulates INHBE gene expression in hepatocytes. INHBE is associated with inhibiting lipolysis, promoting fat storage, and inducing insulin resistance. By silencing this target, MWN117 promotes lipolysis and reduces lipid accumulation. In preclinical models, MWN117 has demonstrated the ability to significantly reduce body fat percentage and visceral fat while simultaneously increasing muscle mass, offering a potential muscle-sparing profile for weight management.

Other names
MWN117 injectionMWN-117 injectionMWN 117 injectionMWN117注射液
02

Targets

INHBE (Inhibin beta E chain)

Beyond the preview

Go deeper on MWN117.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MWN117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call